{"id":"mh004-ointment","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL2108523","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Without publicly available detailed mechanism information, MH004 appears to be a topical pharmaceutical formulation in Phase 3 development by Minghui Pharmaceutical. The specific molecular target and mechanism of action are not clearly disclosed in accessible literature, though the ointment format suggests local skin delivery for a dermatological indication.","oneSentence":"MH004 is a topical ointment formulation designed to treat dermatological conditions through localized therapeutic action.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:49:56.488Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07185282","phase":"PHASE3","title":"A Phase 3 Study of MH004 Ointment in Patients With Mild to Moderate Atopic Dermatitis","status":"COMPLETED","sponsor":"Minghui Pharmaceutical (Hangzhou) Ltd","startDate":"2023-06-10","conditions":"Atopic Dermatitis (AD)","enrollment":375},{"nctId":"NCT07182864","phase":"PHASE1, PHASE2","title":"MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis","status":"COMPLETED","sponsor":"Minghui Pharmaceutical (Hangzhou) Ltd","startDate":"2022-01-06","conditions":"Atopic Dermatitis (AD)","enrollment":160},{"nctId":"NCT07181187","phase":"PHASE2","title":"Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo","status":"ACTIVE_NOT_RECRUITING","sponsor":"Minghui Pharmaceutical (Hangzhou) Ltd","startDate":"2024-03-26","conditions":"Vitiligo","enrollment":156}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"MH004 Ointment","genericName":"MH004 Ointment","companyName":"Minghui Pharmaceutical (Hangzhou) Ltd","companyId":"minghui-pharmaceutical-hangzhou-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}